Moberg Pharma AB (publ) (STO:MOB)
7.90
+0.08 (1.02%)
Oct 31, 2025, 12:47 PM CET
Moberg Pharma AB Revenue
Moberg Pharma AB had revenue of 3.60M SEK in the quarter ending June 30, 2025, a decrease of -12.48%. This brings the company's revenue in the last twelve months to 12.35M, up 150.50% year-over-year. In the year 2024, Moberg Pharma AB had annual revenue of 9.81M.
Revenue (ttm)
12.35M
Revenue Growth
+150.50%
P/S Ratio
30.07
Revenue / Employee
1.37M
Employees
10
Market Cap
371.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.81M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 207.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 33.66M | -16.83M | -33.33% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |